Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.67)
# 3,757
Out of 4,827 analysts
312
Total ratings
19.48%
Success rate
-33.35%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGEN Agenus | Reiterates: Neutral | n/a | $3.04 | - | 16 | Apr 30, 2025 | |
| OLMA Olema Pharmaceuticals | Reiterates: Buy | $30 | $4.67 | +542.40% | 20 | Apr 28, 2025 | |
| SANA Sana Biotechnology | Reiterates: Buy | $11 | $1.81 | +507.73% | 11 | Apr 24, 2025 | |
| BCTX BriaCell Therapeutics | Reiterates: Buy | $32 | $3.18 | +906.29% | 14 | Apr 22, 2025 | |
| RNAZ TransCode Therapeutics | Maintains: Buy | $20 → $10 | $0.35 | +2,755.51% | 17 | Apr 16, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $36 | $20.08 | +79.28% | 1 | Apr 9, 2025 | |
| CNTB Connect Biopharma Holdings | Reiterates: Buy | $8 | $0.79 | +912.53% | 6 | Apr 1, 2025 | |
| IOBT IO Biotech | Reiterates: Buy | $12 | $0.99 | +1,112.12% | 13 | Apr 1, 2025 | |
| GNLX Genelux | Reiterates: Buy | $30 | $2.85 | +952.63% | 7 | Mar 31, 2025 | |
| FEMY Femasys | Reiterates: Buy | $15 | $1.15 | +1,204.35% | 21 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.18 | +1,510.17% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.95 | +823.08% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.84 | +1,576.65% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.81 | +764.41% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.77 | +546.66% | 11 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $6.92 | +405.72% | 12 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.39 | +679.22% | 8 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.26 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $4.43 | +802.93% | 9 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $22 | $19.58 | +12.36% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $8.53 | +181.36% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $58 | $28.04 | +106.85% | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.44 | +3,985.34% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.17 | - | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $17.44 | +117.89% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $6 | $2.46 | +143.90% | 13 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $56.26 | +104.41% | 12 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $2.22 | +1,389.84% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.86 | - | 1 | Apr 25, 2024 |
Agenus
Apr 30, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.04
Upside: -
Olema Pharmaceuticals
Apr 28, 2025
Reiterates: Buy
Price Target: $30
Current: $4.67
Upside: +542.40%
Sana Biotechnology
Apr 24, 2025
Reiterates: Buy
Price Target: $11
Current: $1.81
Upside: +507.73%
BriaCell Therapeutics
Apr 22, 2025
Reiterates: Buy
Price Target: $32
Current: $3.18
Upside: +906.29%
TransCode Therapeutics
Apr 16, 2025
Maintains: Buy
Price Target: $20 → $10
Current: $0.35
Upside: +2,755.51%
vTv Therapeutics
Apr 9, 2025
Initiates: Buy
Price Target: $36
Current: $20.08
Upside: +79.28%
Connect Biopharma Holdings
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $0.79
Upside: +912.53%
IO Biotech
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $0.99
Upside: +1,112.12%
Genelux
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $2.85
Upside: +952.63%
Femasys
Mar 28, 2025
Reiterates: Buy
Price Target: $15
Current: $1.15
Upside: +1,204.35%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.18
Upside: +1,510.17%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.95
Upside: +823.08%
Mar 26, 2025
Reiterates: Buy
Price Target: $14
Current: $0.84
Upside: +1,576.65%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.81
Upside: +764.41%
Mar 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.77
Upside: +546.66%
Mar 18, 2025
Reiterates: Buy
Price Target: $35
Current: $6.92
Upside: +405.72%
Mar 17, 2025
Reiterates: Buy
Price Target: $3
Current: $0.39
Upside: +679.22%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.26
Upside: -
Mar 11, 2025
Reiterates: Buy
Price Target: $40
Current: $4.43
Upside: +802.93%
Mar 4, 2025
Reiterates: Neutral
Price Target: $22
Current: $19.58
Upside: +12.36%
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $8.53
Upside: +181.36%
Feb 24, 2025
Reiterates: Buy
Price Target: $58
Current: $28.04
Upside: +106.85%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $0.44
Upside: +3,985.34%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.17
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $17.44
Upside: +117.89%
Jan 7, 2025
Maintains: Neutral
Price Target: $8 → $6
Current: $2.46
Upside: +143.90%
Dec 10, 2024
Reiterates: Buy
Price Target: $115
Current: $56.26
Upside: +104.41%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $2.22
Upside: +1,389.84%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.86
Upside: -